封面
市場調查報告書
商品編碼
1741531

全球恐慌症治療市場按藥物類別、給藥途徑、分銷管道和地區分類

Global Panic Attack Treatment Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

恐慌症治療市場規模預計在 2025 年達到 29.2 億美元,預計到 2032 年將達到 86.6 億美元,2025 年至 2032 年的年複合成長率為 16.8%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 29.2億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期:2025-2032年年複合成長率: 16.80% 2032年價值預測 86.6億美元

驚恐發作是指突然發生的強烈恐懼和痛苦,可能會使患者虛弱無力。這些發作通常毫無徵兆,並可能引起心悸、呼吸急促和胸痛等身體症狀。恐慌發作的治療著重於緩解症狀、減少發作頻率並改善整體生活品質。

市場動態:

預計恐慌症治療市場將在未來幾年內實現顯著成長。全球市場受多種因素驅動,其中包括全球範圍內恐慌症盛行率的上升。心理健康意識的提升以及對恐慌症的接受度和理解度的提高也促進了市場的成長。此外,醫療技術和治療性介入的進步也推動了更有效的恐慌症治療方法的發展。

然而,也有一些因素限制著市場的成長。該市場面臨的主要挑戰之一是與心理健康問題(包括恐慌症)相關的污名化。這種污名化常常阻礙人們尋求幫助和治療。此外,治療恐慌症的高昂費用以及某些地區較差的報銷政策也構成了市場成長的潛在障礙。

儘管面臨諸多挑戰,市場仍存在著許多機會。人們對能夠有效控制恐慌發作的個人化和標靶治療的需求日益成長。此外,虛擬實境技術與人工智慧在恐慌發作治療中的融合有望為市場擴張開闢新的途徑。此外,製藥業主主要企業加大對研發活動的投入,可能會推動該市場的技術創新,創造成長機會。

本研究的主要特點

  • 本報告對全球恐慌症治療市場進行了詳細分析,包括預測期(2025-2032)的市場規模和年複合成長率(CAGR%),假設 2024 年為基準年。
  • 它揭示了各個領域的潛在商機,並說明了該市場的引人注目的投資提案矩陣。
  • 它提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢和促進因素、區域前景以及主要企業採用的競爭策略的主要考察。
  • 本報告的見解將使負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
  • 全球恐慌症治療市場報告迎合了各種相關人員,例如投資者、供應商、產品製造商、經銷商、新進業者和行業財務分析師。
  • 相關人員可以從用於分析全球恐慌症治療市場的各種策略矩陣中受益,從而促進決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
  • 焦慮和恐慌症呈上升趨勢
    • 限制因素
  • 藥物副作用和安全問題
    • 機會
  • 遠端醫療和電子治療的使用增加
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

4. 全球恐慌症治療市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 2020 年至 2032 年全球恐慌症治療市場(依藥物類別)

  • 抗憂鬱症
  • 抗焦慮藥物
  • CGRP拮抗劑
  • 其他

6. 2020 年至 2032 年按給藥途徑分類的全球恐慌症治療市場

  • 口服
  • 靜脈
  • 肌肉注射
  • 舌下
  • 其他

7. 2020 年至 2032 年全球恐慌症治療市場(依通路分類)

  • 醫院藥房
  • 零售藥局
  • 網路藥局

8. 2020 年至 2032 年全球恐慌症治療市場(按地區)

  • 北美洲
      • 美國
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 歐洲
      • 德國
      • 英國
      • 西班牙
      • 法國
      • 義大利
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • 澳洲
      • 韓國
      • ASEAN
      • 其他亞太地區
  • 中東
      • GCC
      • 以色列
      • 其他中東地區
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第9章 競爭態勢

  • GlaxoSmithKline plc.
  • Hoffmann-La Roche Ltd
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • AstraZeneca
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • Bausch Health Companies Inc.
  • Lundbeck A/S

第 10 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6460

Panic Attack Treatment Market is estimated to be valued at USD 2.92 Bn in 2025 and is expected to reach USD 8.66 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.92 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 16.80% 2032 Value Projection: USD 8.66 Bn

Panic attacks are intense episodes of sudden fear or distress that can be debilitating for individuals who experience them. These attacks often come without warning and can cause physical symptoms such as heart palpitations, shortness of breath, and chest pain. Panic attack treatment focuses on relieving symptoms, reducing the frequency of attacks, and improving overall quality of life.

Market Dynamics:

The Panic Attack Treatment market is expected to witness significant growth in the coming years. The global market is driven by several factors, including the increasing prevalence of panic disorders worldwide. The rising awareness about mental health, coupled with the growing acceptance and understanding of panic attacks, is also contributing to market growth. Additionally, advancements in medical technology and therapeutic interventions have led to the development of more effective treatments for panic attacks.

However, there are certain factors that may restrain the market growth. One of the key challenges in this market is the stigma associated with mental health issues, including panic attacks. This stigma often prevents individuals from seeking help and treatment. Moreover, the high cost of panic attack treatments and a lack of reimbursement policies in some regions are also potential barriers to market growth.

Despite these challenges, several opportunities exist in the market. There is a growing demand for personalized and targeted therapies that can effectively manage panic attacks. Moreover, the integration of virtual reality technology and artificial intelligence in panic attack treatment is expected to open new avenues for market expansion. Additionally, the increasing investments in research and development activities by key players in the pharmaceutical industry are likely to drive innovation in this market and create growth opportunities.

Key Features of the Study:

  • This report provides in-depth analysis of the global Panic Attack Treatment market, including market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), with 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • Key players in the global Panic Attack Treatment market, such as GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Johnson & Johnson Services, Inc., Bausch Health Companies Inc., and H. Lundbeck A/S, are profiled based on company highlights, product portfolios, key highlights, financial performance, and strategies.
  • Insights from this report would allow marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics.
  • The global Panic Attack Treatment market report caters to various stakeholders, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts in the industry.
  • Stakeholders can benefit from various strategy matrices used in analyzing the global Panic Attack Treatment market, which would facilitate ease in decision-making.

Global Panic Attack Treatment Market Segmentation:

  • By Drug Class
    • Antidepressants
    • SSRIs
    • SNRIs
    • TCAs
    • MAOIs
    • Others
    • Anti-anxiety Drugs
    • Benzodiazepines
    • Beta Blockers
    • CGRP Antagonists
    • Others
  • By Route of Administration
    • Oral
    • Intravenous
    • Intramuscular
    • Sublingual
    • Others
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Others
  • By Geography
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles
    • GlaxoSmithKline plc
    • F.Hoffmann-La Roche Ltd
    • Teva Pharmaceutical Industries Ltd.
    • Eli Lilly and Company
    • Bristol-Myers Squibb Company
    • AstraZeneca
    • Pfizer Inc.
    • Johnson & Johnson Services, Inc.
    • Bausch Health Companies Inc.
    • Lundbeck A/S

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Route of Administration
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of anxiety and panic disorders
    • Restraints
  • Side effects and safety issues with medications
    • Opportunities
  • Growing use of telemedicine and e-therapies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Panic Attack Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Panic Attack Treatment Market, By Drug Class, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Antidepressants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Anti-anxiety Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • CGRP Antagonists
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Panic Attack Treatment Market, By Route of Administration, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Intramuscular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Sublingual
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Panic Attack Treatment Market, By Distribution Channel, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Panic Attack Treatment Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,( US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • GlaxoSmithKline plc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Eli Lilly and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bristol-Myers Squibb Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Johnson & Johnson Services, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bausch Health Companies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Lundbeck A/S
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us